Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

Apr 11, 2022


Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Anal

Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

BASEL, Switzerland - April 11, 2022 - (Newswire.com)

Scailyte, a single-cell biomarker discovery company, and Sirona Dx, a leader in multiomic single-cell analytical services, announce a strategic partnership to accelerate the development of Advanced Therapies. The companies will create a powerful biomarker discovery engine, leveraging Sirona Dx technical and laboratory workflow solutions in combination with Scailyte's AI-driven data analytics platform ScaiVision™ to serve Biopharma and Biotech. The joint platform will enable the discovery and validation of ultra-sensitive biomarkers thanks to Sirona Dx leading technical capabilities in single-cell analysis, and the ability of ScaiVision™ to detect complex molecular signatures in biological samples.

The combined workflow will focus on applications within oncology and immunology, including qualification and stratification of patients for clinical trials, analysis of clinical trial results at a deep cellular level or and to advance efficacy and manufacturing processes during CGT development.

The first wave of projects with pharmaceutical and diagnostic companies will begin in Q2-2022.

"We are truly excited to partner with Sirona Dx. Precision medicine in Immuno-Oncology is still a challenge today, which requires full mastery and exploitation of the most advanced multi-omics approaches, including single-cell technologies and analytics. With our combined expertise in single-cell technologies applied to translational science, AI and biomarker discovery, we will provide powerful solutions to our partners to advance the development of immunotherapies," said Corinne Solier, COO at Scailyte AG.

Sirona Dx are original pioneers of single-cell and spatial biology, having launched ultra-high parameter, multiplexed single-cell services to biopharma in 2018. Their innovative, technology-agnostic service capabilities contributed to their selection as a Top 10 CRO of 2021 by Medhealth Outlook.

"We are thrilled to announce this strategic partnership with Scailyte," said Andrew Brown, Ph.D. Chief Commercial Officer at Sirona Dx. "Scailyte have developed an incredibly powerful, AI-driven analytical platform which can successfully tease out the most informative biomarker signatures from complex, single-cell, multi-omic data sets. Our combined expertise in single-cell, multiomic assay development, data generation and state-of-the-art analysis will empower biopharma by providing access to transformative single-cell biomarker capabilities to accelerate their immunotherapy programs."
 

About Sirona Dx

Sirona Dx is a technical CRO, founded to accelerate the pace of immunotherapy and targeted therapy development. Bridging silos between diagnostics manufacturers and translational clinical research our laboratory offers specialized high complexity, single-cell proteomics and genomics services supporting pharmaceutical companies with their drug discovery and development programs. Learn more at Sironadx.com.

About Scailyte

Scailyte AG is a spin-off of ETH Zurich and combines single-cell technologies, high-quality datasets and machine learning methods to identify disease-specific biomarkers, with a focus on oncology and immunology. Scailyte's proprietary best-in-class data analysis platform ScaiVision associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, in order to identify ultra-sensitive biomarker signatures. Thanks to the single-cell resolution and AI-driven approach, ScaiVision is the most powerful and cutting-edge approach to precise diagnosis and prediction of therapy response. Scailyte leverages a broad network of top clinicians to identify clinical indications with high unmet clinical needs and collaborates with global pharmaceutical and biotech companies to translate the novel biomarkers into ultra-sensitive companion diagnostics (CDx) or IVD assays. 

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.


Related Files
Scailyte mini-symposium programme.pdf



Press Release Service by Newswire.com

Original Source: Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

More News

Luistro: Sub judice manifestation vs Tolosa a ‘diversionary tactic’
Nov 11, 2026
Luistro: Sub judice manifestation vs Tolosa a ‘diversionary tactic’

MANILA, Philippines — Lead prosecutor and Batangas Rep. Gerville Luistro on Wednesday characterized as a “diversionary tactic” the defense’s manifestation claiming that a member of the prosecution had violated the impeachment court’s sub judice rule in Vice President Sara Duterte’s trial. On Tuesday, lead defense counsel Sheila Sison filed a manifestation flagging private prosecutors, particularly

DENR urges youth to lead community preparations for Super El Niño
Nov 11, 2026
DENR urges youth to lead community preparations for Super El Niño

LUCENA CITY – The Department of Environment and Natural Resources (DENR) urged the youth to take an active role in protecting their health, conserving natural resources, and supporting their communities as the country braces for a very strong El Niño that is expected to bring prolonged dry conditions through the first half of 2027. During

[Be The Good] Let’s not rely on Leni Robredo
Nov 11, 2026
[Be The Good] Let’s not rely on Leni Robredo

When we look to one person, we miss the opportunity to cultivate a wider selection of politicians

Bukidnon water district gears up as Super El Niño threatens supply
Nov 11, 2026
Bukidnon water district gears up as Super El Niño threatens supply

VALENCIA CITY, Bukidnon — As the country braces for the Super El Niño projected to peak at the end of 2026 and persist until the first half of 2027, the Valencia City Water District (VCWD) here has stepped up proactive measures to protect water security across 17 of the city’s 31 villages. Michael Pornia, VCWD

RESULTS: November 2026 Midwives Licensure Examination
Nov 11, 2026
RESULTS: November 2026 Midwives Licensure Examination

PRESS RELEASE: The Professional Regulation Commission announces that 1,343 out of 2,632 passed the Midwives Licensure Examination

Masungi asserts fight for PH forests as threats remain
Nov 11, 2026
Masungi asserts fight for PH forests as threats remain

MANILA, Philippines — The Masungi Georeserve in Rizal said the “pressure” to preserve what is left of “our forests” is intensifying as threats continue to change. It raised the concern as it reiterated data from the World Resources Institute (WRI), which revealed “a troubling shift in the drivers of intact forest landscape loss.” “At Masungi,

Man nabbed for marijuana he sells to North Cotabato students
Nov 11, 2026
Man nabbed for marijuana he sells to North Cotabato students

COTABATO CITY — Police authorities have arrested a high-value drug suspect and seized from him P430,000 worth of alleged marijuana during the implementation of a search warrant in Kidapawan City, North Cotabato. Brig. Gen. Alan Manibog, Police Regional Office (PRO-12) regional director, said joint personnel of the Kidapawan City Police Office, Philippine Drug Enforcement Agency,

Macalintal files motion for partial reconsideration of SC BSKE ruling
Nov 11, 2026
Macalintal files motion for partial reconsideration of SC BSKE ruling

Election lawyer Romulo Macalintal said that he filed a motion for partial reconsideration before the Supreme Court in relation to its ruling on the Barangay and Sangguniang Kabataan Elections (BSKE).

Evidentiary weight of admission against interest discussed in Sara Duterte impeachment trial 
Nov 11, 2026
Evidentiary weight of admission against interest discussed in Sara Duterte impeachment trial 

Opinions clashed in the impeachment trial of Vice President Sara Duterte on Wednesday on whether which has evidentiary weight between an admission against interest and official public documents.

Sara Duterte impeachment: Defense presents witnesses to counter case
Nov 11, 2026
Sara Duterte impeachment: Defense presents witnesses to counter case

MANILA, Philippines — Several prosecutors may have said that the end is near for Vice President Sara Duterte’s impeachment trial, but this does not mean there will be fewer battles and tense moments, with the defense panel starting to present witnesses meant to demolish the prosecution’s arguments. The defense panel submitted documents to the Senate

Romualdez camp: Ex-speaker’s suspension does not mean guilt
Nov 11, 2026
Romualdez camp: Ex-speaker’s suspension does not mean guilt

MANILA, Philippines — The preventive suspension of former House Speaker Martin Romualdez does not mean he has been found guilty of plunder, especially since his trial is still ongoing, his camp said on Wednesday. Atty. Ade Fajardo, Romualdez’s counsel, said this a day after the Sandiganbayan Third Division imposed a 90-day preventive suspension against Romualdez

AiAi delas Alas' children reveal they tried to fix her marriage with Gerald Sibayan
Nov 11, 2026
AiAi delas Alas' children reveal they tried to fix her marriage with Gerald Sibayan

Aiai delas Alas' children, Sancho and Sophia, revealed that they tried to fix their mother's marriage to Gerald Sibayan.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Voice of KL

We may be unheard, but things are different now. Voice of KL represents the voice of Malaysians who want you to discover the beautiful and developed city of Malaysia.